Cases suffering from early- onset bone cancer have served from a new cooperation blazoned by the Ministry of Health through the National Hospital Insurance Fund( NHIF).
The Ministry of Health formed a new cooperation with Roche, a Swiss pharmaceutical company, to insure Kenyans admit standard care treatment.
READ ALSO: Unlawful acts during elections that can land you to to jail
Cases will now admit a free force of a cancer medicine treatment called Herceptin subcutaneous injection.
The medicine is a targeted anticancer remedy that’s given to adult cases who have early stage bone cancer.
NHIF cardholders with bone cancer will be eligible for the 18- cycle treatment with noco-pays or fiscal scores.
READ ALSO: Ministry of education to make it mandatory for all Teachers to study ICT courses for effective delivery of CBC
Treatment and care for terminal ails, which affect both men and women, imposes a significant fiscal and cerebral burden on cases, driving numerous Kenyans into poverty.
The Health Ministry wants to raise mindfulness about early opinion and get to a point where it can comfortably control the growing complaint.
READ ALSO: New TSC Qualifications for Primary Teachers to teach in junior secondary